Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
Jun 20 2018History
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.1 In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.2 In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.3
Operations
The company has three divisions:4
- ABS - products for cattle
- PIC - products for pigs
- Genus R&D - management of the research and development pipeline for cattle, pigs and other species.
PIC's pedigree herds sire an estimated 30% of commercially reared pigs.5
External links
References
The BSE Inquiry Archived 2008-10-10 at the Wayback Machine http://www.bseinquiry.gov.uk/report/volume12/chapte32.htm ↩
"Genus agrees to acquire ABS Global". Milwaukee Business Journal. 3 August 1999. Retrieved 1 March 2020. https://www.bizjournals.com/milwaukee/stories/1999/08/02/daily5.html ↩
"Genus Completes Acquisition Of Sygen". The Pig Site. Archived from the original on 9 February 2012. Retrieved 28 March 2015. https://web.archive.org/web/20120209234541/http://www.thepigsite.com/swinenews/10541/genus-completes-acquisition-of-sygen ↩
"Genus". Market Watch. Retrieved 25 March 2018. https://www.marketwatch.com/investing/stock/gns/profile?countrycode=uk ↩
Devlin, Hannah (20 June 2018). "Scientists genetically engineer pigs immune to costly disease". The Guardian. Retrieved 11 December 2021. https://www.theguardian.com/science/2018/jun/20/scientists-genetically-engineer-pigs-immune-to-costly-disease ↩